114365-04-7

Basic information

• Product Name: 4-(PYRROLIDIN-1-YL)BENZYLAMINE
• Synonyms: ART-CHEM-BB B022103;[4-(1-PYRROLIDINYL)PHENYL]METHANAMINE;[4-(1-PYRROLIDINYL)PHENYL]METHYLAMINE;4-PYRROLIDINOBENZYLAMINE;4-(PYRROLIDIN-1-YL)BENZYLAMINE;AKOS B022103;[4-(Pyrrolidin-1-yl)phenyl]methylamine 97%;4-(Pyrrolidin-1-yl)benzylamine 97%
• CAS NO: 114365-04-7
• Molecular Formula: C₁₁H₁₆N₂
• Molecular Weight: 176.26
• Mol File: 114365-04-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 327 °C at 760 mmHg
• Flash Point: 132.1 °C
• Appearance: /
• Density: 1.075 g/cm³
• Vapor Pressure: 0.000208mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 9.66±0.10(Predicted)
• CAS DataBase Reference: 4-(PYRROLIDIN-1-YL)BENZYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(PYRROLIDIN-1-YL)BENZYLAMINE(114365-04-7)
• EPA Substance Registry System: 4-(PYRROLIDIN-1-YL)BENZYLAMINE(114365-04-7)

Safety Data

• Hazard Codes: C,Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 114365-04-7(Hazardous Substances Data)

Usage

General Description

4-(Pyrrolidin-1-yl)benzylamine is a chemical compound characterized by a benzylamine group connected to a pyrrolidine ring. It is classified under the category of organic compounds known as benzenoids, which are compounds containing one or more benzene rings. Its systematic name is 1-(phenylmethyl)pyrrolidin-1-amine. Its molecular formula is C12H16N2 and its molecular weight is 188.269 g/mol. This chemical is used as a reagent in the synthesis of various pharmaceutical and medicinal compounds. It's typically in its solid form at room temperature, is highly soluble in water and is considered to be potentially hazardous due to its chemical properties.

InChI:InChI=1/C11H16N2/c12-9-10-3-5-11(6-4-10)13-7-1-2-8-13/h3-6H,1-2,7-9,12H2

Upstream product

• 51980-54-2 4-(pyrrolidin-1-yl)benzaldehyde 
• 623-03-0 4-Cyanochlorobenzene 
• 1194-02-1 4-fluorobenzonitrile 
• 10282-30-1 4-pyrrolidin-1-yl-benzonitrile 
• 148033-58-3 C₁₁H₁₄N₂O 

Downstream Products

• 581812-85-3 1-[4-(isocyanatomethyl)phenyl]pyrrolidine 
• 1338064-52-0 1-(4-(pyrrolidin-1-yl)benzyl)-3-(2,3-dihydro-2-oxo-1H-benzo[d]imidazol-4-yl)urea 
• 389601-87-0 N-[4-(pyrrolidin-1-yl)-phenylmethyl]-3-(biphenyl-2-carbonylamino)-benzoic acid amide 

Relevant articles and documents

NOVEL BRONCHODILATING DIAZAHETEROARYLS

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.

TRPV1 vanilloid receptor antagonists with a bicyclic portion

The invention discloses compounds of formula I wherein Y s selected from a group of formula and W, Q, n, R1, R2, R3, U1-U5 have the meanings given in the description. The compounds of formula I are TRPV1 antagonists and are useful as active ingredients of pharmaceutical compositions for the treatment of pain and other conditions ameliorated by the inhibition of the vanilloid receptor TRPV1. 1.

In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists

The synthesis and structure-activity relationship of 1-(aryl)-3-(4-(amino) benzyl)urea transient receptor potential vanilloid 1 (TRPV1) antagonists are described. A variety of cyclic amine substituents are well tolerated at the 4-position of the benzyl group on compounds containing either an isoquinoline or indazole heterocyclic core. These compounds are potent antagonists of capsaicin activation of the TRPV1 receptor in vitro. Analogues, such as compound 45, have been identified that have good in vivo activity in animal models of pain. Further optimization of 45 resulted in compound 58 with substantially improved microsome stability and oral bioavailability, as well as in vivo activity.